| Primary information |
|---|
| CancerPPD ID | 3546 |
| PMID | 22100226 |
| YEAR | 2012 |
| SEQUENCE | VNWKKILAKIIKVVK |
| LENGTH | 15 |
| NAME | LL-III/1 |
| C-ter Modification | Amidation |
| N-ter Modification | Free |
| Linear/Cyclic | Linear |
| L/D/Mix | L |
| Non-Natural | None |
| NATURE | Antimicrobial and Antifungal |
| ACTIVITY | IC50 = 3±1 µM |
| SOURCE | Lasioglossin III and its analogs |
| Cancer Type | Leukemia Cancer |
| ASSAY | MTT/MTS assay |
| Patent ID | None |
| Tissue | Blood |
| CELL LINE | CCRF-CEM |
| TEST TIME | 48-h |
| Secondary information |
|---|
| STRUCTURE | |
| DSSP states | CCHHHHHHHHHHHCC |
| SMILES | N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N |
| External Links |
|---|
| PDB exact | PDB partial | SP exact | SP partial | TrEMBL exact | TrEMBL partial | IEDB exact | IEDB partial |
| NA | NA | NA | NA | NA | NA | NA | NA |
|